<DOC>
	<DOCNO>NCT00240630</DOCNO>
	<brief_summary>The purpose study determine consistency response Treximet ( sumatriptan/naproxen sodium ) , formerly know Trexima , treat four acute migraine attack mild pain phase within 1 hour onset head pain .</brief_summary>
	<brief_title>Treximet ( Sumatriptan/Naproxen Sodium ) , Formerly Known Trexima , In The Acute Treatment Of Multiple Migraine Attacks</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>At least 6 month history physician diagnose migraine typically experience 26 migraine attack per month . Typically experience moderate severe migraine pain precede mild pain phase . Differentiate mild migraine pain headache type . Women childbearing potential must adequate contraception . Pregnant and/or nursing mother . History cardiovascular disease . Uncontrolled hypertension . Basilar Hemiplegic migraine . History stroke transient ischemic attack ( TIA ) . History epilepsy treat antiepileptic within past 5 year . Impaired hepatic renal function . History gastrointestinal bleeding ulceration . Allergy hypersensitivity Aspirin NSAID . Allergy hypersensitivity triptans . Participated investigational drug trial previous 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>acute migraine</keyword>
	<keyword>consistency response</keyword>
	<keyword>satisfaction</keyword>
	<keyword>migraine</keyword>
	<keyword>early intervention</keyword>
</DOC>